Safety and long‐term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension. (1st September 2018)

• Record Type: Journal Article
• Authors: Watanabe, Shin; Ishikawa, Kiyotake; Plataki, Maria; Bikou, Olympia; Kohlbrenner, Erik; Aguero, Jaume; Hadri, Lahouaria; Zarragoikoetxea, Iratxe; Fish, Kenneth; Leopold, Jane A.; Hajjar, Roger J.
• Is Part Of: Pulmonary circulation. Volume 8:Number 4(2018)
• Page Start: 1
• Page End: 4
• Publication Date: 2018-09-01
• Subjects: gene therapy -- airway delivery -- post‐capillary pulmonary hypertension -- nebulization; Pulmonary circulation -- Periodicals; Pulmonary circulation; Electronic journals -- Sciences; Periodicals; 616.24005
• DOI: 10.1177/2045894018799738
• Languages: English
• ISSNs: 2045-8932

Abstract

Abstract : Nebulization delivery of adeno‐associated virus serotype 1 encoding sarcoplasmic reticulum Ca 2+ ‐ATPase2a (AAV1.SERCA2a) gene was examined in a Yukatan miniature swine model of chronic pulmonary hypertension (n = 13). Nebulization of AAV1.SERCA2a resulted in homogenous distribution of vectors, lower pulmonary vascular resistance, and a trend towards better long‐term survival compared to control animals.